Experimental drug may benefit some patients with rare form of ALS

Some patients with a rare form of ALS benefited from an experimental therapy, with biomarker evidence of reduced injury to neurons and even limited functional recovery.

Some patients with a rare form of ALS benefited from an experimental therapy, with biomarker evidence of reduced injury to neurons and even limited functional recovery.

Read more https://www.sciencedaily.com/releases/2025/05/250523120625.htm